CPC-211: Filed IND to start Phase I trials

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-211, small molecule that penetrates the blood-brain barrier to reduce the accumulation of lactic acid in the brain and facilitate the ...